(CCJ) Cameco - Ratings and Ratios
Uranium, Fuel, Conversion, Reactor, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.19% |
| Yield on Cost 5y | 1.71% |
| Yield CAGR 5y | 16.92% |
| Payout Consistency | 90.8% |
| Payout Ratio | 21.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 51.5% |
| Value at Risk 5%th | 78.8% |
| Relative Tail Risk | -7.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.96 |
| Alpha | 34.45 |
| CAGR/Max DD | 1.40 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.389 |
| Beta | 1.208 |
| Beta Downside | 1.094 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.01% |
| Mean DD | 9.62% |
| Median DD | 6.52% |
Description: CCJ Cameco September 29, 2025
Cameco Corp (NYSE:CCJ) is a vertically integrated uranium producer that generates revenue across three business lines: (1) Uranium – exploration, mining, milling, and the sale of uranium concentrate; (2) Fuel Services – conversion, enrichment, and fabrication of nuclear fuel; and (3) Westinghouse – design, construction, and aftermarket support for commercial nuclear reactors.
The company’s customer base spans nuclear utilities in the Americas, Europe, and Asia, positioning it as a primary supplier in a market where long-term contracts dominate pricing and demand is driven by the global push for low-carbon electricity generation.
Key operational metrics from the most recent fiscal year include production of roughly 12.5 million pounds of U₃O₈, cash flow from operations of about $2.1 billion, and a net debt-to-EBITDA ratio of 0.9×, indicating a relatively strong balance sheet for a capital-intensive commodity business.
Sector-wide, the uranium market is currently influenced by three macro drivers: (i) the tightening of supply as legacy mines close, (ii) government policies that earmark nuclear power as a cornerstone of net-zero strategies, and (iii) price volatility stemming from geopolitical tensions that affect both supply chains and the cost of alternative energy sources.
For a deeper dive into Cameco’s valuation metrics and scenario analysis, the ValueRay platform offers a transparent, data-driven framework worth exploring.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (526.0m TTM) > 0 and > 6% of Revenue (6% = 207.9m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 6.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 36.28% (prev 35.41%; Δ 0.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 1.26b > Net Income 526.0m (YES >=105%, WARN >=100%) |
| Net Debt (228.5m) to EBITDA (1.07b) ratio: 0.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (435.4m) change vs 12m ago -0.02% (target <= -2.0% for YES) |
| Gross Margin 29.05% (prev 23.81%; Δ 5.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 36.41% (prev 30.11%; Δ 6.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.32 (EBITDA TTM 1.07b / Interest Expense TTM 79.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.87
| (A) 0.13 = (Total Current Assets 1.89b - Total Current Liabilities 631.4m) / Total Assets 9.74b |
| (B) 0.36 = Retained Earnings (Balance) 3.49b / Total Assets 9.74b |
| (C) 0.08 = EBIT TTM 744.0m / Avg Total Assets 9.51b |
| (D) 2.22 = Book Value of Equity 6.57b / Total Liabilities 2.96b |
| Total Rating: 4.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.43
| 1. Piotroski 8.0pt |
| 2. FCF Yield 1.93% |
| 3. FCF Margin 28.07% |
| 4. Debt/Equity 0.15 |
| 5. Debt/Ebitda 0.21 |
| 6. ROIC - WACC (= -1.33)% |
| 7. RoE 7.98% |
| 8. Rev. Trend 72.95% |
| 9. EPS Trend 40.47% |
What is the price of CCJ shares?
Over the past week, the price has changed by +11.42%, over one month by -17.21%, over three months by +12.57% and over the past year by +48.88%.
Is CCJ a buy, sell or hold?
- Strong Buy: 10
- Buy: 9
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CCJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 114.6 | 29.5% |
| Analysts Target Price | 114.6 | 29.5% |
| ValueRay Target Price | 134.2 | 51.6% |
CCJ Fundamental Data Overview November 22, 2025
P/E Trailing = 99.9756
P/E Forward = 63.6943
P/S = 10.3334
P/B = 7.7818
P/EG = 3.33
Beta = 1.311
Revenue TTM = 3.46b CAD
EBIT TTM = 744.0m CAD
EBITDA TTM = 1.07b CAD
Long Term Debt = 996.2m CAD (from longTermDebt, last quarter)
Short Term Debt = 289.2m CAD (from shortTermDebt, last fiscal year)
Debt = 1.01b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 228.5m CAD (from netDebt column, last quarter)
Enterprise Value = 50.44b CAD (50.22b + Debt 1.01b - CCE 778.7m)
Interest Coverage Ratio = 9.32 (Ebit TTM 744.0m / Interest Expense TTM 79.9m)
FCF Yield = 1.93% (FCF TTM 972.5m / Enterprise Value 50.44b)
FCF Margin = 28.07% (FCF TTM 972.5m / Revenue TTM 3.46b)
Net Margin = 15.18% (Net Income TTM 526.0m / Revenue TTM 3.46b)
Gross Margin = 29.05% ((Revenue TTM 3.46b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 37.32% (prev 29.31%)
Tobins Q-Ratio = 5.18 (Enterprise Value 50.44b / Total Assets 9.74b)
Interest Expense / Debt = 0.60% (Interest Expense 6.05m / Debt 1.01b)
Taxrate = 101.0% (out of range, set to none) (15.9m / 15.7m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.99 (Total Current Assets 1.89b / Total Current Liabilities 631.4m)
Debt / Equity = 0.15 (Debt 1.01b / totalStockholderEquity, last quarter 6.78b)
Debt / EBITDA = 0.21 (Net Debt 228.5m / EBITDA 1.07b)
Debt / FCF = 0.23 (Net Debt 228.5m / FCF TTM 972.5m)
Total Stockholder Equity = 6.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.40% (Net Income 526.0m / Total Assets 9.74b)
RoE = 7.98% (Net Income TTM 526.0m / Total Stockholder Equity 6.59b)
RoCE = 9.80% (EBIT 744.0m / Capital Employed (Equity 6.59b + L.T.Debt 996.2m))
RoIC = 8.93% (EBIT 744.0m / (Assets 9.74b - Curr.Liab 631.4m - Cash 778.7m))
WACC = 10.26% (E(50.22b)/V(51.22b) * Re(10.47%) + (debt cost/tax rate unavailable))
Discount Rate = 10.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 73.96% ; FCFE base≈710.8m ; Y1≈876.8m ; Y5≈1.50b
Fair Price DCF = 38.93 (DCF Value 16.95b / Shares Outstanding 435.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 40.47 | EPS CAGR: 4.20% | SUE: -0.93 | # QB: 0
Revenue Correlation: 72.95 | Revenue CAGR: 7.75% | SUE: -0.58 | # QB: 0
Additional Sources for CCJ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle